Hyung Heon Kim - 11 Aug 2023 Form 4 Insider Report for NeuroBo Pharmaceuticals, Inc. (MTVA)

Role
CEO & President, Director
Signature
/s/ Phillip D. Torrence, by Power of Attorney
Issuer symbol
MTVA
Transactions as of
11 Aug 2023
Net transactions value
$0
Form type
4
Filing time
14 Aug 2023, 16:10:40 UTC
Previous filing
10 Jun 2022
Next filing
13 Aug 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NRBO Common Stock Award $0 +625,064 $0.000000 625,064 11 Aug 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a grant of restricted stock units ("RSUs") issued to the reporting person under the Issuer's 2022 Equity Incentive Plan.
F2 50% of the RSUs will vest on August 11, 2024, and the remainder will vest in equal monthly installments on the last day of each full month over the subsequent 12 months, subject to continuing service.

Remarks:

Exhibit 24, Power of Attorney, is attached.